As of April 1, 2011, FUJIFILM Corporation completed their acquisition of Merck Biomanufacturing Network.

We are known now as Fujifilm Diosynth Biotechnologies.
We will continue to offer an extensive breadth of process development and commercial cGMP manufacturing experience to meet your needs at every stage of the product lifecycle.

Your browser will be redirected momentarily. If this does not occur, please click here to be redirected.